About
Nexgel Inc (NASDAQ:NXGL) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 27 2026
NEXGEL Appoints Ian Blackman as Chief Financial Officer
Apr 21 2026
NEXGEL New Strategic Partner, Sequence LifeScience™, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment
Apr 21 2026
Celularity Announces Closing of Transaction with NexGel
Apr 17 2026
NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET
Apr 15 2026
NEXGEL Reschedules Shareholder Update Conference Call to April 23rd at 4:30 P.M. ET to Provide Update on Celularity Transaction
Financials
Revenue
$11.42 M
Market Cap
$4.81 M
EPS
-0.38
Translate